Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 71,278 | 73,165 | 63,096 | 75,881 | 58,686 |
| Operating Income | -71,278 | -73,165 | -63,096 | -75,881 | -58,686 |
| Other Income | 6,318 | 7,141 | 7,840 | 8,681 | 9,668 |
| Pre-tax Income | -64,960 | -66,024 | -55,256 | -67,200 | -49,018 |
| Income Tax | 61 | 72 | 83 | N/A | N/A |
| Net Income Continuous | -65,021 | -66,096 | -55,339 | -67,218 | -49,018 |
| Net Income | $-65,021 | $-66,096 | $-55,339 | $-67,218 | $-49,018 |
| EPS Basic Total Ops | -1.11 | -1.13 | -0.95 | -1.20 | -0.86 |
| EPS Basic Continuous Ops | -1.11 | -1.13 | -0.95 | -1.20 | -0.86 |
| EPS Diluted Total Ops | -1.11 | -1.13 | -0.95 | -1.20 | -0.86 |
| EPS Diluted Continuous Ops | -1.11 | -1.13 | -0.95 | -1.20 | -0.86 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.13 | -0.95 | -1.19 | -0.86 |
| EBITDA(a) | $-72,492 | $-74,526 | $-65,268 | $-78,791 | $-62,143 |